Dr. Dickersin's major research interests are related to randomized clinical trials, trials registers, systematic reviews and meta analysis, publication bias, peer review, evidence-based health care, and comparative effectiveness research. She has conducted studies in a number of important subject areas, including women's health, eyes and vision, and surgery.

Dr. Dickersin serves as the Director for the Center for Clinical Trials, whose faculty, staff and students are involved in methodologic research and oversee coordination of data collection and analysis of important clinical trials. She and the Clinical Trials faculty develop and implement the curriculum of the Clinical Trials area of concentration.

She is also Director of the US Cochrane Center, one of 12 Centers worldwide participating in The Cochrane Collaboration (www.cochrane.org). The Collaboration aims to help people make well-informed decisions about health by preparing, maintaining, and promoting the accessibility of systematic reviews of available evidence on the benefits and risks of health care. Dr. Dickersin also serves as an editor of the Cochrane Eyes and Vision Review Group. (CEVG)(www.cochraneeyes.org).

epidemiology, clinical trials, systematic reviews and meta-analysis, evidence-based health care, comparative effectiveness research, publication bias, trials registration, peer review, eyes and vision, women's health, the Cochrane Collaboration

1993 - 1997 Frohlich Fellowship, New York Academy of Sciences.

1994 “Woman of Excellence,” National Association of Women Business Owners, Baltimore Regional Chapter.

1995 Ellen Barnett Memorial Award, Susan B. Komen Foundation Race for the Cure.

1996 Women’s Hall of Fame, Baltimore City Commission for Women.

1998; 2006 “Maryland’s Top 100 Women,” Daily Record.

1998 MAMM magazine’s “50 Who Made a Difference.”

1999 Elected to membership, American Epidemiological Society.

2000 “Exceptional Advocate,” National Breast Cancer Coalition.

2007 "Contributions and Enduring Commitment to the Eradication of Cancer," American Association for Cancer Research.

2007 Elected to membership, Institute of Medicine

2009 JHSPH Student Assembly, Advising, Mentoring, Teaching Recognition Award (AMTRA)

Click here for a full list of Dr. Dickersin's citations in PubMed

Dickersin K, Hewitt P, Mutch L, Chalmers I, Chalmers TC.  Comparison of MEDLINE searching with a perinatal clinical trials database.  Controlled Clin Trials 6:306-317, 1985.

Dickersin K.  The existence of publication bias and risk factors for its occurrence.  JAMA 263:1385-1389, 1990.

Dickersin K, Min Y-I, Meinert CL.  Factors influencing publication of research results: Followup of applications submitted to two institutional review boards.  JAMA 267:374-378, 1992.

Dickersin K, Min Y-I.  NIH clinical trials and publication bias.  Online J Curr Clin Trials 1993 April 28 (Doc No 50): [4967 words. 53 paragraphs]. 

Scherer R, Dickersin K, Langenberg P.  Full publication of results initially presented in abstracts: A meta-analysis.  JAMA 272:158-162, 1994.  Correction JAMA 272:1410, 1994.

Dickersin K, Scherer R, Lefebvre C.  Identification of relevant studies for systematic reviews.  Br Med J 309:1286-1291, 1994.

Ischemic Optic Neuropathy Decompression Trial Research Group (Writing Committee).  Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful: Results of the Ischemic Optic Neuropathy Decompression Trial.  JAMA 273:625-632, 1995.

Ischemic Optic Neuropathy Decompression Trial Research Group (Writing Committee). Ischemic Optic Neuropathy Decompression Trial: Twenty-four month update.  Arch Ophthalmol 118:793-798, 2000.

Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson CD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, for the Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group.  Meta-analysis of observational studies in epidemiology.  A proposal for reporting.  JAMA 283:2008-2012, 2000.

Dickersin K.  How important is publication bias?  A synthesis of available data.  AIDS Edu Prevention 9 (suppl A):15-21, 1997.

Dickersin K, Fredman L, Flegal K, Scott JD, Crawley B.  Is there a sex bias in choosing journal editors?  Epidemiology journals as an example.  JAMA 280:260-264, 1998.

Dickersin K, Braun L, Mead M, Millikan R, Wu AM, Pietenpol J, Troyan S, Anderson B, Visco F. Development and implementation of a science training course for breast cancer activists: Project LEAD (Leadership, Education and Advocacy Development).  Health Expectations 4:213-220, 2001.

Robinson K, Dickersin K.  Development of a highly sensitive search strategy for the retrieval of controlled trials using PubMed. Int J Epidemiol 31:150-153, 2002.

Dickersin K.  Systematic reviews in epidemiology:  Why are we so far behind?  Int J Epidemiol 31:6-12, 2002.

Andejeski Y, Bisceglio IT, Dickersin K , Johnson JE, Robinson SI, Smith HS, Visco FM, Rich I.  Quantitative impact of including consumers in the scientific review of breast cancer research proposals. J Womens Health Gender Based Med 11:379-388, 2002.

Olson CM, Rennie D, Cook D, Dickersin K, Flanagin A, Hogan J, Zhu Q, Reiling J, Pace B.  Publication bias in editorial decision making.  Assessment of reports of controlled trials.  JAMA 287:2825-2828, 2002.

Dickersin K, Scherer R, Suci EST, Gil-Montero M.  Problems with indexing and citation of articles with group authorship.  JAMA 287:2772-2774, 2002.

Newman N, Scherer RS, Langenberg P, Kelman SE, Kaufman D, Feldon S, Dickersin K for the Ischemic Optic Neuropathy Decompression Trial Research Group.  The fellow eye in NAION: Report from the Ischemic Optic Neuropathy Decompression Trial Followup Study.  Am J Ophthalmol 134:317-328, 2002.

Dickersin K, Rennie D. Registering clinical trials.  JAMA 290:516-523, 2003.        

Wieland S, Dickersin K. Selective outcome reporting and indexing limit MEDLINE search sensitivity for observational studies of adverse effects. J Clin Epidemiol 58:560-567, 2005. Erratum 58:6(560-67).

Krleža-Jeriæ K, Chan A-W, Dickersin K, Sim I, Grimshaw J, Gluud C for the Ottawa Group.  Principles for international registration of protocol information and results from human trials of health-related interventions: Ottawa statement (part 1). BMJ 330:956-958, 2005.  Ottawa Group members list and full statement. http://BMJ.com/cgi/content/full/330/7497/956.

Dickersin K, Ssemanda E, Mansell C, Rennie D.  What do JAMA editors say when they discuss manuscripts that they are considering for publication?  Developing a schema for the content of editorial discussion. BMC Med Res Methodology 7:44, 2007.

Dickersin K, Munro MG, Clark MA, Langenberg P, Scherer R, Frick K, Zhu Q, Hallock L, Nichols J, Yalcinkaya T for the STOP-DUB (Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding) Research Group.  Results of a randomized trial comparing hysterectomy and endometrial ablation for dysfunctional uterine bleeding.  Obstet Gynecol 110:1279-89, 2007. 

Frick KF, Clark MA, Steinwachs DM, Langenberg P, Stoval D, Munro MG, Dickersin K, and The STOP DUB Research Group. Financial and quality-of-life burden of dysfunctional uterine bleeding among women agreeing to obtain surgical treatment. Women’s Health Issues. 19:70-78, 2009.

Moher D, Liberati A, Tetzlaff, J, Altman D, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Med 6:7 July, 2009.

Vedula SS, Bero L, Scherer RW, Dickersin K. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med 361:1963-71, 2009.